Consensus-based evaluation of clinical significance and management of anticancer drug interactions.
Jansman FG, Reyners AK, van Roon EN, Smorenburg CH, Helgason HH, le Comte M, Wensveen BM, van den Tweel AM, de Blois M, Kwee W, Kerremans AL, Brouwers JR; Scientific Institute for Dutch Pharmacists (WINAp); Dutch Society for Medical Oncology (NVMO); Dutch Society of Clinical Pharmacology and Biopharmacy (NVKF&B).
Jansman FG, et al. Among authors: wensveen bm.
Clin Ther. 2011 Mar;33(3):305-14. doi: 10.1016/j.clinthera.2011.01.022. Epub 2011 Apr 2.
Clin Ther. 2011.
PMID: 21459447